Dr. Jiwen Zhang is currently leading the regulatory affairs group at Passage Bio, Inc. Before joining Passage Bio, she had worked at Tmunity, GE Healthcare and biopharmaceutical companies including Johnson & Johnson, Merck, Wyeth Pharmaceuticals, and Sanofi-Aventis.
Dr. Zhang has extensive experiences in regulatory development across multiple therapeutic areas, including anti-inflammatory, anti-viral, metabolic, hematology, bone and growth. She has also had experiences in developing drug/device combination products, and medical devices used at cell therapy point of care setting.
Dr. Zhang is leading various industry initiatives through the Standards Coordinating Body, the International Standards Organization (ISO), CASSS, and Asia Pacific Economic Cooperation Regulatory Harmonization Steering Committee (APEC RHSC).
Dr. Zhang obtained her Bachelor of Science degree in Biology from the University of Science and Technology of China and Ph.D. in Neuroscience from the joint program at the Rutgers University and the University of Medicine and Dentistry of New Jersey.